ES2144857T3 - USE OF BENZONAPHTHALENIC DERIVATIVES FOR THE MANUFACTURE OF MEDICINES INTENDED FOR THE TREATMENT OF DISEASES OF THE NERVOUS SYSTEM. - Google Patents

USE OF BENZONAPHTHALENIC DERIVATIVES FOR THE MANUFACTURE OF MEDICINES INTENDED FOR THE TREATMENT OF DISEASES OF THE NERVOUS SYSTEM.

Info

Publication number
ES2144857T3
ES2144857T3 ES97919465T ES97919465T ES2144857T3 ES 2144857 T3 ES2144857 T3 ES 2144857T3 ES 97919465 T ES97919465 T ES 97919465T ES 97919465 T ES97919465 T ES 97919465T ES 2144857 T3 ES2144857 T3 ES 2144857T3
Authority
ES
Spain
Prior art keywords
manufacture
diseases
treatment
nervous system
benzonaphthalenic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97919465T
Other languages
Spanish (es)
Inventor
Xavier Vige
Jesus Benavides
Braham Shroot
Veronique Taupin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Galderma Research and Development SNC
Original Assignee
Galderma Research and Development SNC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galderma Research and Development SNC filed Critical Galderma Research and Development SNC
Application granted granted Critical
Publication of ES2144857T3 publication Critical patent/ES2144857T3/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Abstract

UTILIZACION DE COMPUESTOS DE FORMULA GENERAL (I) PARA LA FABRICACION DE MEDICAMENTOS UTILES EN EL TRATAMIENTO DE LAS NEUROPATIAS PERIFERICAS, DE LAS ENFERMEDADES NEURODEGENERATIVAS CENTRALES Y DE LAS ENFERMEDADES AUTOINMUNES DEL SISTEMA NERVIOSO.USE OF COMPOUNDS OF GENERAL FORMULA (I) FOR THE MANUFACTURE OF MEDICINES USEFUL IN THE TREATMENT OF PERIPHERAL NEUROPATHIES, CENTRAL NEURODEGENERATIVE DISEASES AND NERVOUS SYSTEM DISEASES.

ES97919465T 1996-04-05 1997-04-02 USE OF BENZONAPHTHALENIC DERIVATIVES FOR THE MANUFACTURE OF MEDICINES INTENDED FOR THE TREATMENT OF DISEASES OF THE NERVOUS SYSTEM. Expired - Lifetime ES2144857T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9604359A FR2747041B1 (en) 1996-04-05 1996-04-05 USE OF BENZONAPHTHALENIC DERIVATIVES FOR THE MANUFACTURE OF MEDICINES FOR THE TREATMENT OF NEUROPATHIES

Publications (1)

Publication Number Publication Date
ES2144857T3 true ES2144857T3 (en) 2000-06-16

Family

ID=9490993

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97919465T Expired - Lifetime ES2144857T3 (en) 1996-04-05 1997-04-02 USE OF BENZONAPHTHALENIC DERIVATIVES FOR THE MANUFACTURE OF MEDICINES INTENDED FOR THE TREATMENT OF DISEASES OF THE NERVOUS SYSTEM.

Country Status (23)

Country Link
US (1) US6043280A (en)
EP (1) EP0900078B1 (en)
JP (1) JP2000512619A (en)
KR (1) KR20000005179A (en)
CN (1) CN1221341A (en)
AT (1) ATE189385T1 (en)
AU (1) AU717704B2 (en)
BR (1) BR9708511A (en)
CA (1) CA2250755A1 (en)
CZ (1) CZ317698A3 (en)
DE (1) DE69701258T2 (en)
ES (1) ES2144857T3 (en)
FR (1) FR2747041B1 (en)
GR (1) GR3033061T3 (en)
HU (1) HUP9902167A3 (en)
NO (1) NO984651L (en)
NZ (1) NZ332158A (en)
PL (1) PL329219A1 (en)
PT (1) PT900078E (en)
RU (1) RU2160098C2 (en)
SK (1) SK133398A3 (en)
WO (1) WO1997037648A1 (en)
ZA (1) ZA972875B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JO2178B1 (en) 1999-10-19 2003-04-23 اف . هوفمان لاروش ايه جي Treatment of emphysema using rar selective retinoid antagonists
AU1760201A (en) * 1999-11-12 2001-06-06 Fred Hutchinson Cancer Research Center Methods for treatment of human huntington's disease and methods of screening foractive agents
US6914074B2 (en) * 2001-12-13 2005-07-05 Wyeth Substituted phenyl naphthalenes as estrogenic agents
UA77526C2 (en) * 2002-06-07 2006-12-15 Sanofi Aventis Substituted derivatives of 1-piperazineacylpiperidine, a method for the preparation thereof and their use in therapy
DK2613776T3 (en) 2010-09-01 2020-10-19 Univ Jefferson COMPOSITION AND METHOD FOR MUSCLE REPAIR AND REGENERATION
KR101981930B1 (en) 2017-08-10 2019-05-27 주식회사 에니텍시스 Landing device

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5455248A (en) * 1993-09-14 1995-10-03 Sterling Winthrop Inc. Substituted 6,11-ethano-6,11-dihydrobenzo[b] quinolizinium salts, and compositions and method of use thereof

Also Published As

Publication number Publication date
RU2160098C2 (en) 2000-12-10
SK133398A3 (en) 1999-12-10
EP0900078A1 (en) 1999-03-10
FR2747041A1 (en) 1997-10-10
BR9708511A (en) 1999-08-03
DE69701258D1 (en) 2000-03-09
WO1997037648A1 (en) 1997-10-16
PL329219A1 (en) 1999-03-15
ZA972875B (en) 1997-10-31
HUP9902167A3 (en) 2000-07-28
NO984651D0 (en) 1998-10-05
PT900078E (en) 2000-07-31
HUP9902167A2 (en) 2000-04-28
US6043280A (en) 2000-03-28
JP2000512619A (en) 2000-09-26
CN1221341A (en) 1999-06-30
ATE189385T1 (en) 2000-02-15
FR2747041B1 (en) 1998-05-22
AU2392797A (en) 1997-10-29
CZ317698A3 (en) 1999-02-17
GR3033061T3 (en) 2000-08-31
AU717704B2 (en) 2000-03-30
CA2250755A1 (en) 1997-10-16
KR20000005179A (en) 2000-01-25
NZ332158A (en) 2000-06-23
DE69701258T2 (en) 2000-12-21
NO984651L (en) 1998-12-03
EP0900078B1 (en) 2000-02-02

Similar Documents

Publication Publication Date Title
ES2191192T3 (en) TIENOPIRIMIDINAS.
AR026610A1 (en) A PIRROLIDINACETAMIDE DERIVATIVE ONLY OR IN COMBINATION FOR TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS
ES2086623T3 (en) AZAHETEROCICLILMETIL-CROMANOS AS ACTIVE PRINCIPLES FOR THE TREATMENT OF DISEASES OF THE CENTRAL NERVOUS SYSTEM.
ES2188793T3 (en) AGENT FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES.
BR0309875A (en) methods and compositions for treating peripheral nervous system disorders and novel compounds useful therefor
MX9301348A (en) NEW COMPOUNDS THAT HAVE PHARMACOLOGICAL ACTIVITY, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITION THAT INCLUDES THEM.
ES2132105T3 (en) 2-AMINOMETIL-CHROMANES AS ACTIVE INGREDIENTS IN DRUGS FOR THE TREATMENT OF DISEASES OF THE CENTRAL NERVOUS SYSTEM.
YU1097A (en) 2-oxo and 2-thio-1,2-dihydroquinoilinyl-oxazolidinones
BRPI0407662B8 (en) 1-phenylalkanecarboxylic acid derivatives for the treatment of neurodegenerative diseases
ES2097341T3 (en) SUBSTITUTED INDOLES AS DRUGS FOR THE TREATMENT OF AIDS.
CY1108932T1 (en) Compounds 4- (heterocyclyl) -benzenesulfoximine for the therapeutic treatment of inflammatory diseases
ES2089687T3 (en) 4-PHENYL-PIRIDONES AND 4-PHENYL-2-ALCOXIPIRIDINAS SUBSTITUTED AS INHIBITORS OF HMG-COA-REDUCTASA.
UY27455A1 (en) DERIVATIVES N- (1,4,5,6-TETRAHIDRO-CICLOPENTAPIRAZOL -3-IL) - REPLACED. ITS OBTAINING AND USE AS DRUGS.
TR200200716T2 (en) Quetiapine granules
DE60312736D1 (en) 1,2,4-TRIAMINOBENZOLE DERIVATIVES FOR THE TREATMENT OF DISEASES OF THE CENTRAL NERVOUS SYSTEM
YU13699A (en) Use of 1-hydroxy-2-pyridones for producing pharmaceuticals for the treatment of skin diseases
ATE141605T1 (en) THIENOTRIAZOLDIAZEPINE COMPOUNDS AND THEIR PHARMACEUTICAL USES
ES2124861T3 (en) AMINO ACID DERIVATIVES AND THEIR USE AS ENCEPHALINASE INHIBITORS.
ES2144857T3 (en) USE OF BENZONAPHTHALENIC DERIVATIVES FOR THE MANUFACTURE OF MEDICINES INTENDED FOR THE TREATMENT OF DISEASES OF THE NERVOUS SYSTEM.
AR002272A1 (en) Use of phenylcyclohexylcarboxylic amides
MX9301935A (en) COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE ALTERATIONS.
HUP0100611A2 (en) Triazine compounds for treatment of cns disorders
IT1289154B1 (en) ISOFLAVONE DERIVATIVES THEIR PREPARATION AND THEIR THERAPEUTIC USE
ES2148600T3 (en) SUBSTITUTED INDOL DERIVATIVES.
DE68901172D1 (en) (-) - 2-PYRAZOLINE COMPOUND, THEIR OPTICAL UNLOCKING AND THERAPEUTIC AGENT FOR THE TREATMENT OF CEREBRAL VEGETABLE DISEASES, CONTAINING THIS COMPOUND AS AN ACTIVE INGREDIENT.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 900078

Country of ref document: ES